P15.06 Efficacy and prognostic factors of combined immunochemotherapy R-MPV-A with reduced or deferred radiotherapy for patients with primary CNS lymphoma | Zendy

AI Assistant Blog Pricing

P15.06 Efficacy and prognostic factors of combined immunochemotherapy R-MPV-A with reduced or deferred radiotherapy for patients with primary CNS lymphoma

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.